基本情報
| サイトトップ | https://www.epiprobe.net |
|---|
HTMLサイズ
| 1ページ平均HTML(バイト) | 40068.13 |
|---|
内部リンク集計
| リンク総数 | 82 |
|---|
外部リンク集計
| リンク総数 | 868 |
|---|
メタ情報
| meta description平均長 | 197.73 |
|---|---|
| OGPありページ数 | 6 |
| Twitterカードありページ数 | 0 |
HTML言語 分布
| キー | 割合 |
|---|---|
| en | 73.33% |
文字コード 分布
| キー | 割合 |
|---|---|
| utf-8 | 73.33% |
内部リンク分析(Internal)
| ユニーク内部リンク数 | 82 |
|---|---|
| ページあたり内部リンク平均 | 32.27 |
内部リンク 深さヒストグラム
| キー | 値 |
|---|---|
| 0 | 52 |
| 1 | 409 |
| 2 | 23 |
内部リンク 上位URL
キーワード分析(KeywordMap)
ワードクラウド上位
| 語 | 重み |
|---|---|
| https | 1 |
| www | 1 |
| net | 1 |
| weekly | 1 |
| epiprobe | 0.833105 |
| genome | 0.313742 |
| endometrial | 0.204825 |
| endometrium | 0.18777 |
| genomics | 0.14261 |
| molecular | 0.12053 |
| uterine | 0.114088 |
| healthcare | 0.090192 |
| health | 0.083189 |
| cancer | 0.077241 |
| hyperplasia | 0.076059 |
| diagnostic | 0.076044 |
| test | 0.070738 |
| solutions | 0.068445 |
| carcinoma | 0.059421 |
| pcr | 0.059421 |
| sequencing | 0.057044 |
| diagnostics | 0.052266 |
| laboratory | 0.049517 |
| Hospital | 0.047537 |
| human | 0.047537 |
| ivd | 0.042783 |
| vitro | 0.042443 |
| dna | 0.042443 |
| gene | 0.040675 |
| ultrasound | 0.038029 |
| software | 0.035652 |
| treatment | 0.033902 |
| uterus | 0.033276 |
| polyps | 0.033276 |
| testing | 0.031832 |
| rapid | 0.030899 |
| proliferative | 0.030899 |
| pathology | 0.028522 |
| stage | 0.028522 |
| kit | 0.027963 |
| University | 0.026145 |
| sarcoma | 0.026145 |
| detection | 0.024931 |
| thickened | 0.023768 |
| causes | 0.023768 |
| cervical | 0.023142 |
| management | 0.02299 |
| types | 0.02299 |
| serous | 0.021391 |
| genes | 0.021222 |
共起語上位
| 語1 | 語2 | スコア | 共起ページ数 |
|---|---|---|---|
| https | www | 3.636786 | 3448 |
| epiprobe | net | 3.626027 | 3445 |
| epiprobe | www | 3.623025 | 3447 |
| https | weekly | 3.622622 | 3441 |
| Biotechnology | Ltd | 3.044428 | 27 |
| Hospital | University | 2.991235 | 39 |
| engagement | patient | 2.884057 | 24 |
| Test | method | 2.816348 | 20 |
| Fluorescence | method | 2.816348 | 20 |
| Fluorescence | quantitative | 2.816348 | 20 |
| PCR | quantitative | 2.816348 | 20 |
| Packing | specification | 2.816348 | 20 |
| Biotechnology | Epiprobe | 2.714217 | 30 |
| diagnostics | molecular | 2.629059 | 131 |
| cutting | edge | 2.628545 | 16 |
| acid | nucleic | 2.628545 | 16 |
| kits | qpcr | 2.626152 | 28 |
| health | solutions | 2.616254 | 89 |
| healthcare | solutions | 2.595083 | 105 |
| Test | specimens | 2.576049 | 20 |
| Sample | type | 2.482833 | 20 |
| Epiprobe | Shanghai | 2.476916 | 33 |
| specification | tests | 2.461962 | 20 |
| diagnostic | vitro | 2.411356 | 59 |
| Biotechnology | Shanghai | 2.403898 | 24 |
| Fudan | University | 2.393471 | 18 |
| manufacturer | supplier | 2.387905 | 12 |
| rates | survival | 2.387905 | 12 |
| one | step | 2.387905 | 12 |
| Detection | Kits | 2.385199 | 16 |
| endometrial | hyperplasia | 2.373783 | 119 |
| hypermethylation | qualitative | 2.318824 | 15 |
| Fluorescence | Test | 2.318824 | 15 |
| method | quantitative | 2.318824 | 15 |
| Fluorescence | PCR | 2.318824 | 15 |
| DNA | methylation | 2.308637 | 32 |
| detection | methylation | 2.28649 | 46 |
| real | time | 2.27378 | 12 |
| Kits | qPCR | 2.27378 | 12 |
| acid | extraction | 2.27378 | 12 |
| management | software | 2.27202 | 28 |
| PCR | Sample | 2.237846 | 15 |
| disordered | proliferative | 2.234606 | 20 |
| polyps | uterine | 2.214576 | 44 |
| cancer | endometrial | 2.193859 | 251 |
| Bladder | Cancer | 2.185257 | 12 |
| intraepithelial | neoplasia | 2.159655 | 12 |
| Epiprobe | Ltd | 2.154473 | 21 |
| endometrium | proliferative | 2.148617 | 51 |
| dna | tagme | 2.111025 | 24 |